Trevo NXT ProVue Retriever— 510(k) K210502

Name: FDA 510(k) clearance K210502
Creator: U.S. Food and Drug Administration
Published: 2021-08-27

Substantially Equivalent

Stryker Neurovascular

FDA 510(k) clearance K210502 for Trevo NXT ProVue Retriever, Substantially Equivalent on 2021-08-27. Applicant: Stryker Neurovascular. Device class: 2.

Clearance details

Applicant: Stryker Neurovascular
Product code: Product code POL
Device class: Class 2
Regulation: 21 CFR 882.5600
Advisory panel: Neurology
Date received: 2021-02-22
Decision date: 2021-08-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Fremont, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code POL

view all

K242676 — pRESET Delta Thrombectomy Device and pRESET Delta LITE Thrombectomy Device2025-02-28
K231539 — pRESET LITE Thrombectomy Device2023-10-21
K223305 — Trevo NXT ProVue Retriever2023-03-29
K222848 — pRESET Thrombectomy Device2023-01-20
K203358 — Solitaire X Revascularization Device2021-03-01

More clearances from Stryker Neurovascular

view all

K261649 — Excelsior Reach Microcatheter2026-10-09
K261889 — Trevo Trak 21 Microcatheter2026-07-01
K253032 — AXS Lift Intracranial Base Catheter2026-02-11
K252694 — Target Detachable Coil2025-12-11
K251832 — InZone IST Detachment System; IZDS Connecting Cable2025-10-17

Data sourced from openFDA. This site is unofficial and independent of the FDA.